Mouse brain study reveals why blockbuster weight-loss drugs may work differently in females and males

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the treatment of obesity and diabetes so thoroughly that…

Continue Reading

News Source: medicalxpress.com